Clinical Trial Update: A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2) [Phase 3]

View source ↗

Summary

Phase 3 study update (Study 2 of 2) evaluating a sumatriptan succinate and naproxen sodium combination for migraine in patients with poor response or intoleranc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2010-04-20